WO2021195789A1 - Flow assay cartridge - Google Patents
Flow assay cartridge Download PDFInfo
- Publication number
- WO2021195789A1 WO2021195789A1 PCT/CA2021/050451 CA2021050451W WO2021195789A1 WO 2021195789 A1 WO2021195789 A1 WO 2021195789A1 CA 2021050451 W CA2021050451 W CA 2021050451W WO 2021195789 A1 WO2021195789 A1 WO 2021195789A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cartridge
- flow assay
- assay
- engagement feature
- flow
- Prior art date
Links
- 238000007836 assay cartridge Methods 0.000 title claims abstract description 156
- 238000003556 assay Methods 0.000 claims abstract description 122
- 239000012528 membrane Substances 0.000 claims abstract description 81
- 238000012360 testing method Methods 0.000 claims abstract description 51
- 230000000295 complement effect Effects 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 9
- 238000002405 diagnostic procedure Methods 0.000 claims description 4
- 238000004458 analytical method Methods 0.000 abstract description 11
- 238000012125 lateral flow test Methods 0.000 abstract description 9
- 239000000523 sample Substances 0.000 description 59
- 239000012530 fluid Substances 0.000 description 32
- 238000001514 detection method Methods 0.000 description 27
- 239000003153 chemical reaction reagent Substances 0.000 description 26
- 239000000872 buffer Substances 0.000 description 24
- 239000000463 material Substances 0.000 description 15
- 238000013461 design Methods 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000000758 substrate Substances 0.000 description 10
- 239000012491 analyte Substances 0.000 description 9
- 206010020751 Hypersensitivity Diseases 0.000 description 8
- 230000007815 allergy Effects 0.000 description 8
- 239000000427 antigen Substances 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 238000013096 assay test Methods 0.000 description 7
- 238000003018 immunoassay Methods 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- 235000013305 food Nutrition 0.000 description 6
- -1 molecules Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 208000026935 allergic disease Diseases 0.000 description 5
- 238000003908 quality control method Methods 0.000 description 5
- 238000012800 visualization Methods 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- 229920000058 polyacrylate Polymers 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000013566 allergen Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 229920000515 polycarbonate Polymers 0.000 description 3
- 239000004417 polycarbonate Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 206010048908 Seasonal allergy Diseases 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 229920001600 hydrophobic polymer Polymers 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 239000011104 metalized film Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000002165 resonance energy transfer Methods 0.000 description 2
- 239000012146 running buffer Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000589968 Borrelia Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 1
- 108091008102 DNA aptamers Proteins 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000007811 Latex Hypersensitivity Diseases 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 108091008103 RNA aptamers Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 206010039251 Rubber sensitivity Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000007813 chromatographic assay Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 201000005391 latex allergy Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 201000005299 metal allergy Diseases 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 201000004338 pollen allergy Diseases 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000012206 semi-quantitative assay Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/02—Adapting objects or devices to another
- B01L2200/025—Align devices or objects to ensure defined positions relative to each other
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/02—Adapting objects or devices to another
- B01L2200/028—Modular arrangements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/10—Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/041—Connecting closures to device or container
- B01L2300/042—Caps; Plugs
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/041—Connecting closures to device or container
- B01L2300/043—Hinged closures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0825—Test strips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0848—Specific forms of parts of containers
- B01L2300/0851—Bottom walls
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/4875—Details of handling test elements, e.g. dispensing or storage, not specific to a particular test method
- G01N33/48757—Test elements dispensed from a stack
Definitions
- the present invention pertains to a flow assay cartridge for housing and protecting a flow assay membrane or lateral flow test strip which can be vertically stacked and is adapted for high-throughput automated lateral flow assay testing and analysis.
- the flow assay cartridge comprises top and bottom engagement features such that two or more flow assay cartridges can be releasably adjoined such that they can be vertically stacked and easily handled by an automated assay apparatus.
- Immunological flow assay tests also referred to as immunoassays, exist for a wide array of target analytes including monitoring ovulation, detecting infectious disease organisms, analyzing drugs of abuse, and measuring other analytes important to human physiology such as the presence of microorganisms, pharmaceuticals, hormones, viruses, antibodies, nucleic acids, and other proteins.
- antibodies can be detected on flow assay membranes as indicators of various disease states and immunological status by detecting the formation of a complex between a detector particle that is free in the sample stream and a capture reagent that is bound to the membrane at a test line.
- Flow assay devices have also been employed for qualitative, semi-quantitative, and quantitative measurement of small amounts of materials in biological samples in healthcare, veterinary testing, agricultural applications, food safety, environmental testing, and product quality evaluation.
- samples which may be useful for testing are blood, milk, urine, serum, plant materials or extracts, and food samples.
- test design has progressed toward semi-quantitative and quantitative assays, and flow assay membranes are now being used with the integration of hand-held readers and high throughput analyzers and laboratory or point-of-care devices.
- Various types of analyzers can enable concurrent diagnostic testing at a plurality of flow assay devices and provide an integrated and robust sample-processing system with concurrent testing such that a plurality of flow assay devices can be incubated and processed concurrently.
- Flow assay membranes and associated cartridges can be designed that use small test volumes such that results can be obtained using high performance visualization to provide qualitative and quantitative results.
- a flow assay cartridge houses and protects a flow assay membrane, also known as a lateral flow test strip, before, during, and after flow assay analysis, and is particularly useful in combination with high throughput analyzers.
- Automated systems that can process a multitude of lateral flow assay devices at a time can decrease sample turn-around time and provide high throughput in assay testing and analysis.
- One example lateral flow assay apparatus for use in clinical diagnostics is described in United States patent US9,709,562 to Jakubowicz et al. in which a plurality of lateral flow assay devices can be retained in an automated assay analyzer.
- robust flow assay cartridges which can be easily handled provide reliability, safety, and reproducibility in a high throughput system.
- Such automated systems can be deployed as point of care diagnostic systems for use by technicians while still providing reliable and reproducible results.
- An object of the present invention is to provide a flow assay cartridge for housing and protecting a flow assay membrane or lateral flow test strip which is adapted for high- throughput automated lateral flow assay testing and analysis.
- a flow assay cartridge comprising: a cartridge base; a cartridge lid engageable with the cartridge base; a bottom engagement feature on the cartridge base; and a top engagement feature, wherein the bottom engagement feature of a first flow assay cartridge can be engaged with the top engagement feature of a second flow assay cartridge positioned below the first flow assay cartridge for releasable sliding engagement of the second flow assay cartridge to the first flow assay cartridge.
- a flow assay cartridge comprising: a cartridge base; a cartridge lid engageable with the cartridge base; a bottom engagement feature; and a top engagement feature for releasable engagement with the bottom engagement feature of a second flow assay cartridge positioned above the flow assay cartridge.
- the releasable engagement of the top engagement feature with the bottom engagement feature of the second flow assay cartridge is a sliding engagement.
- the top engagement feature and bottom engagement feature comprise a rail track and a complementary rail guide.
- the top engagement feature comprises a rail track and the bottom engagement feature comprises at least one rail guide.
- the bottom engagement feature and the top engagement feature are friction-fit engagement features, snap-fit engagement features, or a combination thereof.
- the cartridge is releasably vertically stackable with a plurality of similar cartridges.
- the cartridge lid is covered by the cartridge base of the second flow assay cartridge.
- the cartridge further comprises a flow assay membrane in the cartridge.
- the cartridge further comprises features for engagement with an analyzer.
- the cartridge lid is reversibly engaged to the cartridge base.
- the cartridge lid has a plurality of apertures.
- a method of flow assay automation comprising: disengaging a first assay cartridge from a vertically engaged stack of assay cartridges; applying sample to the first assay cartridge to begin the assay; and reengaging the first assay cartridge to another assay cartridge in the plurality of vertically engaged stack of assay cartridges.
- disengaging of a first assay cartridge from the vertically engaged stack of assay cartridges is done by an automated device.
- disengaging of a first assay cartridge from the vertically engaged stack of assay cartridges is done by sliding the first assay cartridge away from the stack of assay cartridges.
- a diagnostic test device comprising: a flow assay membrane; and a flow assay cartridge for receiving the flow assay membrane, the cartridge comprising: a cartridge base; a cartridge lid engageable with the cartridge base; a bottom engagement feature; and a top engagement feature for releasable engagement with the bottom engagement feature of a second flow assay cartridge positioned above the flow assay cartridge.
- a diagnostic test device comprising: a flow assay membrane; and a flow assay cartridge for receiving the flow assay membrane, the cartridge comprising: a cartridge base; a cartridge lid engageable with the cartridge base; a bottom engagement feature on the cartridge base; and a top engagement feature, wherein the bottom engagement feature of a first flow assay cartridge can be engaged with the top engagement feature of a second flow assay cartridge positioned below the first flow assay cartridge for releasable sliding engagement of the second flow assay cartridge to the first flow assay cartridge.
- the releasable engagement is a sliding engagement.
- test device further comprises a mounting locus where an analyzer component can engage with the assay cartridge for secure transport in the analyzer.
- the bottom engagement feature and the top engagement feature are friction-fit engagement features, snap-fit engagement features, or a combination thereof.
- the bottom engagement feature and the top engagement feature comprise at least one rail track and at least one rail guide.
- the bottom engagement feature and the top engagement feature comprise at least two rail tracks and at least two rail guides.
- Figure 1 is an isometric view of multiple engaged flow assay cartridges
- Figure 2 is an isometric view of the bottom of a flow assay cartridge
- Figure 3 is a top isometric view of a lid and base of a flow assay cartridge
- Figure 4 is an isometric cross-sectional view of a flow assay cartridge
- Figure 5 is a bottom isometric view of a lid of a flow assay cartridge
- Figure 6 is a top isometric view of the base of a flow assay cartridge
- Figure 7a is an isometric view of the closing side of a flow assay cartridge
- Figure 7b is an isometric view of the opening side of a flow assay cartridge
- Figure 8 is a side cross-sectional view of a flow assay cartridge
- Figure 9 is an isometric view of a flow assay membrane
- Figure 10 is a front view of a vertically engaged stack of flow assay cartridges; and [0043] Figure 1 1 is a front view of a cartridge base with engagement features.
- connection refers to any direct or indirect physical association between elements or features of the present disclosure. Accordingly, these terms may be understood to denote elements or features that are partly or completely contained within one another, attached, coupled to, disposed on, joined together, in communication with, operatively associated with, or fluidically coupled to, etc., even if there are other elements or features intervening between the elements or features described as being connected.
- flow assay membrane and "lateral flow test strip” are used interchangeably herein to refer to a generally planar substrate used to elute a component of interest.
- the flow assay membrane is preferably made from one or more suitable porous or non-porous materials with surface properties that support capillary like flow.
- the flow assay membrane receives a sample and/or sample or buffer fluid and includes a fluid transport or flow path along which various areas or sites are provided for supporting one or more reagents, filters, and the like and through which sample traverses under the influence of capillary action or other forces.
- Flow assay membranes can include but are not limited to thin-film or "dry slide" test elements, lateral flow assay devices, microfluidic paper-based analytical devices ( PADs), vertical flow assay devices, and chromatography devices.
- the flow assay membrane also refers to the carrier or matrix or combination of membranes to which a sample is added, and on or in which the determination is performed, or where the reaction between analyte and reagent takes place.
- Membranes come in a wide variety of sizes, with more common sizes of 2-10mm wide and from 30-100mm long.
- sample refers to a volume of a liquid, fluid, solution, or suspension, intended to be subjected to qualitative or quantitative determination of any of its properties or components, such as the presence or absence of a component, the concentration of a component, etc.
- Typical samples in the context of the present invention as described herein are derived from human or animal bodily fluids such as but not limited to blood, plasma, serum, lymph, urine, saliva, semen, amniotic fluid, gastric fluid, phlegm, sputum, mucus, tears, stool, etc.
- Other types of samples are derived from human or animal tissue samples where the tissue sample has been processed into a liquid, solution, or suspension to reveal particular tissue components for examination.
- Other non-limiting examples of samples that can be used are environmental samples, food industry samples, and agricultural samples.
- Analytes of interest can include, but are not limited to antibodies, hormones, molecules, antigens, organic chemicals, biochemicals, and proteins.
- antibodies include antibodies that bind food antigens, and antibodies that bind infectious agents such as virus and bacteria, for example anti-CCP, anti-streptolysin-O, anti- HIV, anti-hepatitis (anti-HBc, anti-HBs etc), antibodies against Borrelia, and specific antibodies against microbial proteins.
- the term "analyzer” as used herein, refers to any apparatus enabling the automated processing of various analytical test or flow assay devices, and in which a plurality of test devices can be processed.
- the analyzer can comprise a plurality of components configured for loading, incubating, testing, transporting, and evaluating a plurality of analytical test elements in an automated or semi-automated fashion and in which sample and/or other fluids may be automatically dispensed and processed substantially without user intervention.
- Analyzers include but are not limited to clinical diagnostic apparatus and point-of-care type devices.
- reaction refers to any interaction which takes place between components of a sample and at least one reagent or reagents on or in, or added to, the substrate of the test device, or between two or more components present in the sample.
- reaction is used to define the reaction taking place between an analyte and a reagent on the test device as part of the qualitative or quantitative determination of the analyte.
- the flow assay cartridge for housing and protecting a flow assay membrane or lateral flow test strip which is adapted for high-throughput automated lateral flow assay testing and analysis.
- the flow assay cartridge comprises engagement features such that two or more flow assay cartridges can be releasably adjoined in a vertical stack or configuration such that multiple flow assay cartridges can be easily handled by an automated assay apparatus.
- the presently described assay cartridge can be used in automated or semi- automated lateral flow assay analyzers and point-of-care diagnostic devices.
- the flow assay cartridge houses and protects a flow assay strip or flow assay membrane and provides robustness during manufacture, distribution, storage, and for transport and movement of the flow assay strip in an automated analyzer.
- a solid assay cartridge is further capable of being moved by one or more moving mechanisms in an analyzer without damage, disruption, or contamination to the planar substrate of the flow assay membrane strip and detection area within.
- the following exemplary embodiments relate to the configuration and design of a flow assay cartridge which is vertically connectable to one or more other flow assay cartridges.
- FIG. 1 is an isometric view of a stack of four flow assay cartridges with slidable vertical engagement with the bottom flow assay cartridge in the stack slide out relative to the cartridges above it.
- Each individual assay cartridge has a cartridge base 4 or base which houses a flow assay membrane and a cartridge lid 6.
- the cartridge base 4 is capable of receiving and supporting a flow assay membrane for diagnostic flow assay testing and can have a variety of interior configurations for supporting, holding, and maintaining the integrity of the flow assay membrane.
- the cartridge lid 6 comprises a plurality of apertures that can be used for receiving various samples, reagents and/or fluids, and for visualising the flow assay membrane at various times including before, during, and after the flow assay membrane has been eluted.
- the exemplified cartridge comprises a buffer port 20, a sample addition port 22, two quality control (qc) windows 34a and 34b, and a results window 26 through which to view the results of the assay. It is understood that the number and placement and design of apertures in the cartridge lid 6 can be varied depending on the assay design desired and the structure of the flow assay membrane.
- the flow assay cartridge comprises vertical engagement features to enable vertical engagement of two or more cartridges such that cartridges can be engaged and disengaged from one another.
- vertical stacking of engaged flow assay cartridges can enable efficient cartridge storage, packing, orientation, and handling, enabling movement and transport of a stack of assay cartridges as a single unit.
- handling of multiple assay cartridges at a time saves time in handling and reduces the risk of error.
- Cartridges can also be packaged together and supplied in an engaged vertical stack for ease of handling.
- protection of open apertures on the lid of each assay cartridge during transport and incubation is provided by the cartridge above in the vertical stack.
- the flow assay membrane inside the flow assay cartridge can be provided with protection during transport, including in an automated or semi- automated analyzer and/or during handling, as well as locally controlled humidity during assay running.
- covering the apertures on the top of the flow assay cartridge during elution can delay evaporation of the buffer or eluent and also provide a local chamber which is protected from contamination and/or humidity loss during elution of the assay test.
- the flow assay cartridge shown has a sliding rail track 32 on the cartridge lid 6 which serves as a top engagement feature, and is configured to receive and engage with one or bottom engagement features (not shown) on the bottom of the assay cartridge above it, where the bottom engagement features slidingly fit inside the rail track 32.
- rail track 32 on a bottom assay cartridge engages in a sliding arrangement with a rail guide (not shown) on the base of the cartridge above it such that the rail guide slides into the rail track 32, forming a secure but reversible sliding engagement.
- the rail track and engaged rail guide design can enable linear sliding of the engaged flow assay cartridges in both directions, in particular enabling cartridge sliding and/or separation from both the buffer port 20 end of the cartridge and the opposite end of the flow assay cartridge.
- one or more stopping feature can be provided either on the cartridge lid 6 or cartridge base 4 to restrict sliding of the slide rail 32 relative to the rail guide in one direction only, or prevent complete separation of the vertically stacked assay cartridges as desired.
- Any combination of top engagement feature and bottom engagement feature that provides sliding releasable engagement of two vertically stacked assay cartridges can be employed, including various configurations of linear sliding engagement features as shown, as well as friction fit engagement features, and combinations thereof.
- Rail track 32 shown is a dovetail slide, with matching dovetail rail guides on the cartridge base.
- top engagement feature and bottom engagement feature can be anywhere on the cartridge which enable vertical stacking of two cartridges in a reversibly securable manner.
- the two features of the longitudinal rail track (elongated channel) and a complementary rail guide (feature that can be slidingly received in the channel) can each be either on the top or bottom of the cartridge, providing that together they can be joined in a releasable but securable way.
- Friction fit engagement of two cartridges can also be used, including using malleable or deformable materials for the slide and/or rail such that two cartridges can be reversibly disengaged and re-engaged and aligned using a snapping motion, or features which provide the same functionality, such as, for example, two or more deformable post and/or aperture arrangements.
- the assay cartridge can also have one or more optional barcode 46, which can be any digital data stored as an image that can be read by an optical reader.
- the assay cartridge can have one or more other identification tags such as, for example, an RFID tag or electromagnetic label.
- Figure 2 is an isometric view of the bottom of a flow assay cartridge 2 having an engaged cartridge lid 6 and cartridge base 4.
- the bottom of the assay cartridge has slidable longitudinal bottom engagement features comprising a plurality of rail guides 44a, 44b, 44c, 44d that fit slidably into the rail track in the top of the assay cartridge.
- the cartridge base can also optionally have one or more mounting locus 40 to provide a location where an analyzer component can engage with the assay cartridge for secure transport in the analyzer.
- the mounting locus can be a sliding or friction fit engagement location for mounting with a complementary feature on the analyzer and can be, for example, a linear slide, track, or guide, or one or more aperture for receiving a complementary peg or protrusion in the analyzer.
- Complementary protrusions in a movement mechanism of an automated analyzer can engage with the mounting locus 40 to provide a site for secure reversible engagement for movement of the cartridge in an automated or semi-automated analyzer. It is understood that any configuration of mounting locus or other mounting features on the cartridge would have utility in reversible coupling of the assay cartridge with the analyzer movement mechanism such that the assay cartridge can be separated from another assay cartridge with which it is engaged, moved by the movement mechanism in the analyzer for application of sample, mobile fluid, or any other fluid, for visualization and analysis of the assay results, and for generally moving the assay cartridge around the analyzer.
- a movement mechanism of an automated analyzer can engage with the analyzer engagement apertures complementary to the mounting locus 40, and slidably disengage the assay cartridge from the assay cartridge above it.
- any configuration of mounting features on the cartridge can fit together with a specific physical interference such that sliding friction keeps vertical cartridge stacks substantially together during handling outside of the automated analyzer.
- the engagement of two assay cartridges along the bottom engagement feature of a first cartridge and a top engagement feature of a second cartridge can have sufficient friction to maintain the cartridges in a vertically stacked configuration but still allow sliding movement when sufficient force is applied.
- FIG. 3 is a top isometric view of a cartridge lid 6 and cartridge base 4 of a two-piece flow assay cartridge 2.
- the cartridge base 4 has a base, two long sides, and two short sides, and supports a flow assay membrane which is held in place in a cavity above the cartridge base bottom, and can be further held in place with engagement of the cartridge base with the cartridge lid 6.
- the flow assay cartridge 2 encapsulates a lateral flow assay membrane or strip while enabling addition of buffer, sample, any additional agents, and detection of reaction, while protecting the flow assay membrane during cartridge handling.
- Separate cartridge lid 6 engages with cartridge base 4 to secure and protect the lateral flow assay membrane inside the cartridge.
- the cartridge lid 6 can be secured to the cartridge base 4 using a combination of clasps and clasp apertures, as well as friction due to interference of engagement features to prevent cartridges freely sliding apart.
- clasps 24a, 24c, 24e (and other clasps on the opposite side of the cartridge lid) in the cartridge lid 6 engage with complementary clasp apertures in the cartridge base 4 to provide secure sites of engagement of the cartridge lid 6 with the cartridge base 4.
- Other clasping and complementary clasping arrangements are also possible, including post and aperture clasps, clips, and other friction-fit clasps, optionally with locking features.
- the cartridge lid 6 can also be reversibly or irreversibly engaged with the cartridge base 4, and selection and design of the complementary clasp features on the cartridge base and lid will depend on the desired setup of the assay.
- a hinge or permanent attachment feature of the lid and cartridge can also be used to align and engage the cartridge lid and cartridge base.
- a results port 26 in the cartridge lid 6 is positioned around or above the detection area to enable one or more detector to detect reaction in the detection area of the flow assay membrane inside the cartridge.
- Various configurations of lateral flow assay devices are known, including but not limited to variation in device dimensions, materials, porosity of the substrate, presence or absence of topographical features on the substrate, channel shape and configuration, and method of manufacturing of the channel and/or flow assay membrane.
- the cartridge lid 6 also provides various ports for addition of mobile fluid, sample, reagent, binding agents, detection agents, control binding partners, labeled antibodies, and other materials for running the desired assay, and for detection of presence or absence of a component.
- Buffer port 20 can be used for addition of mobile fluid inside the cartridge and into a buffer well and/or directly onto the flow assay membrane.
- One or more sample addition port 22 is used for adding one or more samples and/or reagents through the cartridge lid to the flow assay membrane.
- the cartridge lid can also have one or more control or quality control windows 34 or apertures to enable visualization of the flow assay membrane inside the cartridge to confirm the validity of an assay test, to confirm the presence or absence of a particular substance or structure, or to confirm the integrity of the flow assay membrane before, during, or after the assay is run.
- a rail track is formed adjacent the mating surface between the cartridge lid 6 and the cartridge base 4 upon engagement.
- Rail guide 44 in the bottom of the cartridge base 4 serves as a bottom engagement feature and fits into the rail track formed between the engaged cartridge lid 6 and cartridge base 4.
- the cartridge base can comprise multiple individual or continuous guiding engagement features or guides 44, and there are preferably at least two short guides or at least one long guide on each of the long sides of the bottom of the cartridge base 4.
- the rail guides comprise a plurality of protrusions from the base of the cartridge and the rail track is configured to receive the rail guides.
- the rail guide is a continuous protrusion and the rail track has one or more indentations configured to fit and engage with the rail guide(s).
- sliding engagement mechanisms can be used, including but not limited to sliding dovetail track and guide(s), and sliding tongue and groove track and guide(s).
- engagement between two cartridges can be a releasable friction fit, and comprise complementary protrusions and apertures wherein alignment of the protrusions and apertures provide a releasable connection between two cartridges.
- Any configuration of engagement features can be designed such that vertically stacked cartridges stay together during handling, but are easily separated by the analyzer movement mechanism.
- Figure 4 is an isometric cross-sectional view of an engaged cartridge base 4 and cartridge lid 4 of a flow assay cartridge 2, showing the internal structure of the cartridge.
- the cartridge base 4 shown has rail guides 44a, 44b, 44c which allow slidable vertical engagement in a rail track of another flow assay cartridge engaged below in a vertical arrangement.
- Buffer port 20 provides access through the cartridge lid 6 to buffer well 42.
- Sample addition port 22 and quality control window 34, results window 26, and additional control window 28 provide access to the flow assay membrane housed inside cartridge for application of materials, as well as for testing and analysis purposes.
- Flow assay membranes which can be received in the assay cartridge and optionally supported by the floor of the cartridge base are generally narrow and long, and sample is applied at one of the end of the membrane and carried by a mobile fluid to a detection region.
- Various chromatographic and immunoassays are known in the art and can be used with the presently described assay cartridge.
- FIG. 5 is a bottom isometric view of a removable cartridge lid 6 of a flow assay cartridge.
- Cartridge lid 6 shown has a plurality of apertures or windows for visualization or detection of the flow assay membrane, as well as a plurality of ports for enabling physical contact with and application of materials, substances, fluids, and/or samples with the flow assay membrane. Shown are buffer port 20, sample addition port 22, quality control window 34, and results window 26, however it is understood that other cartridge lid designs may have different numbers and types of ports and apertures depending on the design and requirements of the assay.
- These components allow for samples and liquids to be added and results to be analysed from the cartridge one or more optional membrane guide can assist in positioning the flow assay membrane in the right orientation and in the preferred position inside the cartridge.
- membrane guide 30 shown extends from the bottom side of the cartridge lid at the buffer port 20 to push down on the conjugate pad of the flow assay membrane when the cartridge lid 6 is engaged with a cartridge base to angle the conjugate pad such that it makes contact with the buffer well and any buffer inside the buffer well to facilitate fluid flow.
- FIG. 6 is a top isometric view of the cartridge base 4 of a flow assay cartridge with a removable cartridge lid.
- the cartridge base 4 has two cartridge long sides 10a, 10b and two cartridge short sides 12a, 12b.
- the cartridge base 4 has a plurality clasp apertures 16a, 16b,
- Buffer well 42 receives running buffer or fluid and used by the flow assay membrane for running of the assay.
- Figure 7a is an isometric view of the closing side of a flow assay cartridge with a hinged cartridge lid.
- Cartridge lid 6 is aligned with cartridge base 4 through hinge 14.
- the hinge working with other components, facilitates a proper alignment to firmly attach the cartridge lid 6 to the cartridge base 4.
- Figure 7b is an isometric view of the opening side of a flow assay cartridge with cartridge lid 6 and cartridge base 4 attached by a hinge.
- Clasps 24a, 24b, 24c, 24d, 24e align with clasp apertures 16a, 16b, 16c, 16d, 16e, respectively, to secure the cartridge lid 6 to the cartridge base 4.
- this configuration is shown with a single construction hinged flow assay cartridge it is understood that a similar configuration of clasps and complementary clasp apertures can be employed in a two-piece construction.
- Figure 8 is a side cross-sectional view of a flow assay cartridge for receiving a flow assay membrane.
- Buffer port 20 receives running fluid into buffer well 42 which stores running buffer.
- Sample addition port 22 is an aperture for introducing sample to the flow assay membrane.
- Results window 26 provides visual access to the detection area of the flow assay membrane where results can be visualized or imaged.
- One or more additional control window or quality control window can be present in the cartridge lid to confirm the presence of components prior to the assay or to confirm the validity of the test results once the test is finished.
- Rail guides 44a, 44b, 44c, 44d facilitate the vertical engagement of another assay cartridge below the one shown by engaging with a longitudinal rail track on the assay cartridge below.
- Figure 9 is an isometric view of an example of a flow assay test strip 50 or flow assay membrane that can be used with the presently described flow assay cartridge.
- a lateral flow assay the introduction of sufficient buffer or fluid sample to a conjugate pad 52 or sample addition area on a flow assay membrane spontaneously induces capillary flow along the assay membrane toward the detection area of the membrane.
- the direction of fluid flow along the membrane also referred to as the fluid flow path, is shown by the arrow.
- Test strip shown comprises, in the direction of fluid flow, a conjugate pad 52, a sample addition area 56, a detection area 58, and a wicking area 54.
- sufficient sample and mobile fluid can be applied directly to a sample addition area or sample pad to provide adequate capillary flow in the membrane of the test strip without the requirement for additional buffer or running fluid.
- conjugate pad 52 at the first end of the fluid flow path draws sample fluid in the desired direction along the lateral flow test strip from a buffer well or buffer port in the cartridge.
- a wick at the wicking area 54 provides a capillary force to draw up and move mobile fluid or buffer into the membrane of the test strip and through the sample addition area 56 of the test strip.
- the wicking area 54 can include a porous material such as, for example, nitrocellulose.
- Conjugate pad 52 is optionally bendable, shown extending off from an optional solid support 60, to accommodate a lowered buffer well in the assay cartridge base and further positioned by an optional wick guide in the assay cartridge base and/or lid.
- Obvious asymmetry in the design of the flow assay strip also provides ease of assembly of the flow assay strip within the assay cartridge and provides a directionality of the flow path so that the flow assay strip is properly aligned inside the cartridge.
- a hydrophilic foil or layer can be positioned directly onto at least a portion of the assay membrane to enhance the overall flow rate or process time of a sample applied to the flow assay device.
- the test strip can also optionally comprise one or more flow channels, optionally cut or pressed into the surface of the membrane substrate.
- the fluid flow path may also include additional separate areas containing one or more reagents, antibodies, or detection conjugate, as well other areas or sites along the fluid path that can be utilized used for washing of the sample and any bound or unbound components thereof.
- the assay membrane can also be optionally treated to adjust the sample properties, such as, for example, by pH level or viscosity.
- An optional lid or cover can be placed on top of the test strip downstream the sample addition area 56 as a physical protection for downstream section of the lateral flow test strip 50, with transparency to the test detection device in the detection area 58 such that the results of the assay can be detected without removing the flow assay strip from the cartridge.
- Detection area 58 comprises an immobilized binding species capable of binding an analyte of interest in a sample such that upon presence of the analyte of interest in an applied sample, with optional addition of a detectable species, the analyte of interest binds to the immobilized binding species and can be detected.
- sample addition area 56 also commonly referred to as a sample pad, receives sample, optionally via a dispenser in an automated analyzer, through a sample port in the cartridge lid.
- Sample applied to the sample addition area 56 is picked up by buffer drawn into the test strip 50 and flows on the substantially planar substrate of the assay membrane from the sample addition area under the capillary force created along the fluid flow path extending through the reaction area or detection area 58 on the assay membrane substrate towards the wicking area 54.
- One or more reagent or detection agent can either be added to or pre-loaded onto the membrane before or during the running of the assay in a location on the membrane between the sample addition area 56 and upstream the detection area 58, which in some immunoassay devices is referred to as a conjugate release area.
- the reagent addition area may be used to add an interrupting reagent that can be used to wash the sample and other unbound components present in the fluid flow path into wicking area 54.
- Reagent can either be added in the reagent area prior to use and potentially dried on the reagent area, added to the reagent area just prior to use using a reagent metering device on the analyzer, or both.
- the reagent can also be added via an optional reagent metering device.
- Reagents that can be added include but are not limited to binding partners such as antibodies or antigens for immunoassays, detection agents, conjugated antibodies, tagging molecules, fluorophores, biomarker specific antibodies, DNA and RNA aptamers with or without resonance energy transfer (RET) pairs and respective target analytes, substrates for enzyme assays, probes for molecular diagnostic assays, and auxiliary materials such as materials that stabilize the integrated reagents, materials that suppress interfering reactions, and the like.
- binding partners such as antibodies or antigens for immunoassays, detection agents, conjugated antibodies, tagging molecules, fluorophores, biomarker specific antibodies, DNA and RNA aptamers with or without resonance energy transfer (RET) pairs and respective target analytes
- substrates for enzyme assays probes for molecular diagnostic assays
- auxiliary materials such as materials that stabilize the integrated reagents, materials that suppress interfer
- the reagents may react with the analyte directly or through a cascade of reactions to form a detectable signal such as a colored or fluorescent molecule.
- the reagent area includes conjugate material.
- conjugate means any moiety bearing both a detection element and a binding partner.
- the detection area 58 comprises one or more test lines and one or more control lines and results or reaction occurs on the detection area 58 which can be detected through the results window in the assay cartridge.
- the test strip 50 can also comprise an optional filter material which can be placed within and/or downstream the sample addition area 56 to filter particulates from the sample, for example to filter or trap blood cells or particulate matter from blood so that added plasma can travel through the device.
- Components of the flow assay devices such as the physical structure of the device described herein can be prepared from, for example, copolymers, blends, laminates, metallized foils, metallized films or metals, waxes, adhesives, or other suitable materials known to the skilled person, and combinations thereof.
- device components can be prepared from copolymers, blends, laminates, metallized foils, metallized films or metals deposited on any one or a combination of the following materials or other similar materials known to the skilled person: paraffins, polyolefins, polyesters, styrene containing polymers, polycarbonate, acrylic polymers, chlorine containing polymers, acetal homopolymers and copolymers, cellulosics and their esters, cellulose nitrate, fluorine containing polymers, polyamides, polyimides, polymethylmethacrylates, sulfur containing polymers, polyurethanes, silicon containing polymers, other polymers, glass, and ceramic materials.
- components of the device can be made with a plastic, polymer, elastomer, latex, silicon chip, or metal.
- the elastomer can comprise polyethylene, polypropylene, polystyrene, polyacrylates, silicon elastomers, or latex.
- components of the device can be prepared from latex, polystyrene latex or hydrophobic polymers.
- the hydrophobic polymer can comprise polypropylene, polyethylene, or polyester.
- components of the device can comprise TEFLON ® , polystyrene, polyacrylate, or polycarbonate.
- device components can be made from plastics which are capable of being embossed, milled or injection molded or from surfaces of copper, silver and gold films upon which may be adsorbed various long chain alkanethiols.
- the structures of plastic which are capable of being milled or injection molded can comprise, for example, a polystyrene, a polycarbonate, a polyacrylate, or cyclo-olefin polymer.
- the present cartridge system is particularly useful for immunoassay formats which are typically sandwich assays wherein the membrane is coated with a capture antibody, sample is added, and any antigen present binds to the capture antibody.
- a detecting antibody binds to antigen in the sample
- an enzyme-linked secondary antibody binds to the detecting antibody or to the antigen
- a substrate in the fluid is converted by the enzyme into a detectable form.
- detection can be done automatically using a visualization system such as a camera or other detection system.
- Figure 10 is a front view of a stack of three flow assay cartridges.
- rail guides 44a, 44b fit into rail tracks 32a, 32b, respectively, to form a secure and reversible sliding engagement such that two cartridges can slide relative to one another.
- Sliding engagement of multiple cartridges provides an organized and safe way of transporting sets of cartridges from manufacturer to use site while limiting movement of cartridges to limit damage to the assay membrane strip housed inside.
- stacks of cartridges with related assay membrane assays can be packaged together for easy loading into an analyzer.
- Each cartridge can also preferably be able to be friction snapped onto another cartridge by applying pressure to move rail guides 44a, 44b in the cartridge base 4 away from each other as shown by arrow 'A' such that they can fit over the wide top of cartridge lid 6 and be positioned into rail tracks 32a, 32b.
- This snap fit feature can be useful when cartridges in two stacks are desired to be fit together to be analysed in a single assay run by an analyzer, or when a single cartridge is desired to be added to an existing stack.
- cartridges as described can be provided with a wide variety of assay membranes having a wide variety of immobilized species in the detection area of the assay membrane.
- assay membranes can be placed into the cartridges for testing for different analytes of interest in a sample, allowing multiple tests to be done on a single sample in a single analyzer run.
- a variety of sets of assay cartridges can be available to point-of-care centres for testing, providing a lot of information about the contents of a particular sample by testing multiple analytes of interest at a time with a single cartridge set.
- the water sample can be tested for the presence of multiple microorganisms by providing a set of assay membranes each with a different immobilized species to detect one or more microorganisms.
- Applications of modular sets of vertical stacks of assay membrane cartridges can also be very useful in antibody testing for various antibodies using an automated analyzer.
- various sets of assay cartridges can be provided which are pre-prepared with a variety of antigens to test if a patient has the antibodies for a particular antigen.
- a set of cartridges for "pet" allergies can be provided to a point of care centre that has individual cartridges to test for the presence of, for example, cat dander, dog dander, horse dander, rodent dander.
- the set can comprise individual cartridges for testing the allergens that cause the majority of food allergies, specifically milk, eggs, peanuts, tree nuts, soy, wheat, fish, and shellfish.
- the two sets of cartridges can be provided to the point-of-care center and engageably stacked together such that the allergy tests for all of the allergens in both sets can be done in a single analyzer run with a single biological sample from the patient.
- Other allergy kits with different sets of allergens can also be provided, such as, for example, for drug allergy, insect allergy, latex allergy, grass allergy, mold allergy, metal allergy, and pollen allergy, to name a few.
- Figure 1 1 is a front view of a cartridge base with engagement features.
- a plurality of rail guides 44 are shown which serve as bottom engagement features configured to slidingly engage with a rail track of another cartridge below it.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202180027446.1A CN115812147A (en) | 2020-04-03 | 2021-04-02 | Flow detection cartridge |
AU2021250481A AU2021250481A1 (en) | 2020-04-03 | 2021-04-02 | Flow assay cartridge |
JP2022560253A JP2023519626A (en) | 2020-04-03 | 2021-04-02 | flow assay cartridge |
US17/906,924 US20230127232A1 (en) | 2020-04-03 | 2021-04-02 | Flow assay cartridge |
EP21781787.3A EP4127709A4 (en) | 2020-04-03 | 2021-04-02 | Flow assay cartridge |
KR1020227038478A KR20220166297A (en) | 2020-04-03 | 2021-04-02 | flow assay cartridge |
CA3172434A CA3172434A1 (en) | 2020-04-03 | 2021-04-02 | Flow assay cartridge |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063004670P | 2020-04-03 | 2020-04-03 | |
US63/004,670 | 2020-04-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021195789A1 true WO2021195789A1 (en) | 2021-10-07 |
Family
ID=77927785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2021/050451 WO2021195789A1 (en) | 2020-04-03 | 2021-04-02 | Flow assay cartridge |
Country Status (8)
Country | Link |
---|---|
US (1) | US20230127232A1 (en) |
EP (1) | EP4127709A4 (en) |
JP (1) | JP2023519626A (en) |
KR (1) | KR20220166297A (en) |
CN (1) | CN115812147A (en) |
AU (1) | AU2021250481A1 (en) |
CA (1) | CA3172434A1 (en) |
WO (1) | WO2021195789A1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219529A (en) * | 1987-07-07 | 1993-06-15 | Unisyn Technologies, Inc. | Cartridge assembly |
US20080167578A1 (en) * | 2005-11-30 | 2008-07-10 | Abbott Diabetes Care, Inc. | Integrated Meter for Analyzing Biological Samples |
WO2010036808A1 (en) * | 2008-09-24 | 2010-04-01 | Straus Holdings Inc. | Kits and devices for detecting analytes |
WO2012012779A2 (en) * | 2010-07-23 | 2012-01-26 | Beckman Coulter Inc. | System and method including analytical units |
US20130092614A1 (en) * | 2011-10-18 | 2013-04-18 | Central Garden And Pet Company | Wedge-Shaped Filter Cartridge |
US20140158713A1 (en) * | 2011-10-24 | 2014-06-12 | Joseph A. King | Dispenser Kits and Method of Increasing Versatility of Inline Dispensers |
WO2020124255A1 (en) * | 2018-12-21 | 2020-06-25 | Exvivo Labs Inc. | Flow assay analyzer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001096193A2 (en) * | 2000-06-12 | 2001-12-20 | Incyte Genomics, Inc. | Microscope slide container |
-
2021
- 2021-04-02 JP JP2022560253A patent/JP2023519626A/en active Pending
- 2021-04-02 CN CN202180027446.1A patent/CN115812147A/en active Pending
- 2021-04-02 WO PCT/CA2021/050451 patent/WO2021195789A1/en active Application Filing
- 2021-04-02 KR KR1020227038478A patent/KR20220166297A/en unknown
- 2021-04-02 CA CA3172434A patent/CA3172434A1/en active Pending
- 2021-04-02 AU AU2021250481A patent/AU2021250481A1/en active Pending
- 2021-04-02 EP EP21781787.3A patent/EP4127709A4/en active Pending
- 2021-04-02 US US17/906,924 patent/US20230127232A1/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219529A (en) * | 1987-07-07 | 1993-06-15 | Unisyn Technologies, Inc. | Cartridge assembly |
US20080167578A1 (en) * | 2005-11-30 | 2008-07-10 | Abbott Diabetes Care, Inc. | Integrated Meter for Analyzing Biological Samples |
WO2010036808A1 (en) * | 2008-09-24 | 2010-04-01 | Straus Holdings Inc. | Kits and devices for detecting analytes |
WO2012012779A2 (en) * | 2010-07-23 | 2012-01-26 | Beckman Coulter Inc. | System and method including analytical units |
US20130092614A1 (en) * | 2011-10-18 | 2013-04-18 | Central Garden And Pet Company | Wedge-Shaped Filter Cartridge |
US20140158713A1 (en) * | 2011-10-24 | 2014-06-12 | Joseph A. King | Dispenser Kits and Method of Increasing Versatility of Inline Dispensers |
WO2020124255A1 (en) * | 2018-12-21 | 2020-06-25 | Exvivo Labs Inc. | Flow assay analyzer |
Non-Patent Citations (1)
Title |
---|
See also references of EP4127709A4 * |
Also Published As
Publication number | Publication date |
---|---|
EP4127709A1 (en) | 2023-02-08 |
EP4127709A4 (en) | 2024-04-03 |
CA3172434A1 (en) | 2021-10-07 |
JP2023519626A (en) | 2023-05-11 |
KR20220166297A (en) | 2022-12-16 |
AU2021250481A1 (en) | 2022-12-01 |
CN115812147A (en) | 2023-03-17 |
US20230127232A1 (en) | 2023-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6387072B2 (en) | Immunoassay kit and analytical method using the same | |
AU2005309443B2 (en) | Device and method for detection of analytes | |
EP2972331B1 (en) | Microfluidic distributing device | |
JP4351539B2 (en) | Method and apparatus for accurately moving and manipulating fluid by centrifugal force and / or capillary force | |
CN104718454B (en) | Possess lateral flow assay strip and the lateral flow assay test kit for this strip of auxiliary mat | |
EP2902784B1 (en) | Assay device using porous medium | |
US20110124130A1 (en) | Device and method for analysis of samples with depletion of analyte content | |
JP6261736B2 (en) | Multiwell cuvette with integrated reaction and detection means | |
US20070287198A1 (en) | Directed-flow assay device | |
US8058079B2 (en) | Method of detecting analytes in a microfluidic sample and a system for performing the same | |
WO2006047831A1 (en) | Detection device and method | |
US20180306785A1 (en) | Lateral flow assay devices and methods | |
JP2008544289A (en) | Membrane array and analytical equipment | |
JP7429990B2 (en) | flow assay analyzer | |
US20230127232A1 (en) | Flow assay cartridge | |
US20040053419A1 (en) | Test device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21781787 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 3172434 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2022560253 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20227038478 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2021781787 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2021781787 Country of ref document: EP Effective date: 20221103 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021250481 Country of ref document: AU Date of ref document: 20210402 Kind code of ref document: A |